131 related articles for article (PubMed ID: 12583545)
21. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
Nord CE; Lindmark A; Persson I
J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
[No Abstract] [Full Text] [Related]
22. A comparison of a new oral streptogramin XRP 2868 with quinupristin-dalfopristin against antibiotic-resistant strains of haemophilus influenzae, Staphylococcus aureus, and Streptococcus pneumoniae.
Mabe S; Champney WS
Curr Microbiol; 2005 Dec; 51(6):363-6. PubMed ID: 16252133
[TBL] [Abstract][Full Text] [Related]
23. Antibacterial activity of cefditoren against major community-acquired respiratory pathogens recently isolated in Italy.
Stefani S; Mezzatesta ML; Fadda G; Mattina R; Palù G; Rossano F; Tufano MA; Schito GC; Nicoletti G
J Chemother; 2008 Oct; 20(5):561-9. PubMed ID: 19028617
[TBL] [Abstract][Full Text] [Related]
24. Comparative activity of six beta-lactam antibiotics against strains of Haemophilus influenzae, Neisseria meningitidis and Streptococcus pneumoniae.
Soares LA; Melles CE
Infection; 1982; 10 Suppl 3():S234-7. PubMed ID: 6818156
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antibacterial activity of novel 4''-carbamates of 6,11-di-O-methylerythromycin A.
Wu Z; Lu Y; Luo M; He X; Xiao Y; Yang J; Pan Y; Qiu G; Xu Y; Huang W; Long P; Li R; Hu X
J Antibiot (Tokyo); 2010 Jul; 63(7):343-50. PubMed ID: 20448668
[TBL] [Abstract][Full Text] [Related]
26. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010].
Wang H; Liu YL; Chen MJ; Xu YC; Sun HL; Yang QW; Hu YJ; Cao B; Chu YZ; Liu Y; Zhang R; Yu YS; Sun ZY; Zhuo C; Ni YX; Hu BJ
Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb; 35(2):113-9. PubMed ID: 22455967
[TBL] [Abstract][Full Text] [Related]
27. [Bactericidal action of chloramphenicol and synergism with beta-lactam antibiotics].
Guggenbichler JP
Padiatr Padol; 1983; 18(1):11-20. PubMed ID: 6403908
[TBL] [Abstract][Full Text] [Related]
28. Comparative in vitro activity of thiamphenicol-glycinate and thiamphenicol-glycinate-acetylcysteinate and other antimicrobials against respiratory pathogens.
Drago L; De Vecchi E; Fassina MC; Mombelli B; Tocalli L; Gismondo MR
Arzneimittelforschung; 2001; 51(4):315-24. PubMed ID: 11367873
[TBL] [Abstract][Full Text] [Related]
29. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
Jacobs E; Dalhoff A; Korfmann G
Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
[TBL] [Abstract][Full Text] [Related]
30. High nasopharyngeal carriage of drug resistant Streptococcus pneumoniae and Haemophilus influenzae in North Indian schoolchildren.
Jain A; Kumar P; Awasthi S
Trop Med Int Health; 2005 Mar; 10(3):234-9. PubMed ID: 15730507
[TBL] [Abstract][Full Text] [Related]
31. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R
J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
[TBL] [Abstract][Full Text] [Related]
32. [Role of thiamphenicol in the treatment of community-acquired lung infections].
Raymond J; Boutros N; Bergeret M
Med Trop (Mars); 2004; 64(1):33-8. PubMed ID: 15224555
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial susceptibility patterns of Haemophilus influenzae and Streptococcus pneumoniae isolates in a Beirut general university hospital between 2000 and 2004.
Daoud Z; Cocozaki A; Hakime N
Clin Microbiol Infect; 2006 Jan; 12(1):86-90. PubMed ID: 16460553
[TBL] [Abstract][Full Text] [Related]
34. Antibacterial activity of nine oral antibiotics against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis.
Renkonen OV
Scand J Infect Dis Suppl; 1983; 39():106-8. PubMed ID: 6606222
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953
[TBL] [Abstract][Full Text] [Related]
36. Comparative activity of cefodizime and ceftriaxone against respiratory pathogens in an in vitro pharmacodynamic model simulating concentration-time curves.
Blandino G; Milazzo I; Musumeci R; Nicolosi VM; Speciale A; Nicoletti G
J Chemother; 2000 Dec; 12(6):503-8. PubMed ID: 11154034
[TBL] [Abstract][Full Text] [Related]
37. Inoculum effect and bactericidal activity of cefditoren and other antibiotics against Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis.
Soriano F; Coronel P; Gimeno M; Jiménez M; García-Corbeira P; Fernández-Roblas R
Eur J Clin Microbiol Infect Dis; 1996 Sep; 15(9):761-3. PubMed ID: 8922582
[TBL] [Abstract][Full Text] [Related]
38. Relationship between in vitro susceptibility test results for chloramphenicol and production of chloramphenicol acetyltransferase by Haemophilus influenzae, Streptococcus pneumoniae, and Aerococcus species.
Matthews HW; Baker CN; Thornsberry C
J Clin Microbiol; 1988 Nov; 26(11):2387-90. PubMed ID: 3266221
[TBL] [Abstract][Full Text] [Related]
39. In vitro antibacterial activity and beta-lactamase stability of cefodizime, a new cephalosporin antibiotic.
Kasai K; Tsuji A; Miyazaki S; Goto S; Fujimoto K; Masuyoshi S; Arai S
Jpn J Antibiot; 1984 Jul; 37(7):1294-305. PubMed ID: 6092739
[TBL] [Abstract][Full Text] [Related]
40. In vitro antibacterial activity of fluorinated analogs of chloramphenicol and thiamphenicol.
Syriopoulou VP; Harding AL; Goldmann DA; Smith AL
Antimicrob Agents Chemother; 1981 Feb; 19(2):294-7. PubMed ID: 6957162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
